Terms: = Thyroid cancer AND PAX8, ENSG00000125618, 7849
447 results:
1. Diagnostic Value of Immunostaining for thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (pax8) in Distinguishing Pulmonary Metastases of Mesonephric and Mesonephric-like Adenocarcinomas from Primary Lung Adenocarcinomas.
Ji N; Lee Y; Lee SH; Kim HS
Anticancer Res; 2024 May; 44(5):2159-2170. PubMed ID: 38677751
[TBL] [Abstract] [Full Text] [Related]
2. Anaplastic and poorly differentiated thyroid carcinomas: genetic evidence of high-grade transformation from differentiated thyroid carcinoma.
Gu H; Wang J; Ran W; Li G; Hu S; Zhao H; Wang X; Wang J
J Pathol Clin Res; 2024 Mar; 10(2):e356. PubMed ID: 38602501
[TBL] [Abstract] [Full Text] [Related]
3. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
4. Liver Mass as First-Time Diagnosis of Sarcomatoid Anaplastic thyroid Carcinoma: A Rare Malignancy Presenting at an Unexpected Body Site.
Kamashki A; Rivera M; Sturgis CD
Am J Case Rep; 2023 Dec; 24():e941838. PubMed ID: 38041397
[TBL] [Abstract] [Full Text] [Related]
5. Relationship between PIWIL1 gene polymorphisms and epithelial ovarian cancer susceptibility among southern Chinese woman: a three-center case-control study.
Liu S; Yan Y; Cui Z; Feng H; Zhong F; Liu Z; Li Y; Ou X; Li W
BMC Cancer; 2023 Nov; 23(1):1149. PubMed ID: 38012622
[TBL] [Abstract] [Full Text] [Related]
6. Divergent Lineage Markers in Anaplastic thyroid Carcinoma.
Mneimneh WS; Asa SL
Am J Surg Pathol; 2024 Feb; 48(2):230-237. PubMed ID: 37972932
[TBL] [Abstract] [Full Text] [Related]
7. Intrathyroid thymic carcinoma: A clinicopathological analysis of 22 cases.
Gao Y; Pan Y; Luo Y; Cheng R; Zhai Q
Ann Diagn Pathol; 2023 Dec; 67():152221. PubMed ID: 37925863
[TBL] [Abstract] [Full Text] [Related]
8. Neoplasms in Struma Ovarii: A Review.
Tondi Resta I; Sande CM; LiVolsi VA
Endocr Pathol; 2023 Dec; 34(4):455-460. PubMed ID: 37864665
[TBL] [Abstract] [Full Text] [Related]
9. thyroid hormone receptor α1: a novel regulator of thyroid cancer cell differentiation.
Hwang E; Doolittle WKL; Zhu YJ; Zhu X; Zhao L; Yu Y; Cheng SY
Oncogene; 2023 Oct; 42(41):3075-3086. PubMed ID: 37634007
[TBL] [Abstract] [Full Text] [Related]
10. [Clinicopathological features of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma].
Zhu M; Li J; Zheng WH; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):820-826. PubMed ID: 37527987
[No Abstract] [Full Text] [Related]
11. Non-hyalinizing trabecular thyroid adenoma: a novel thyroid tumor with diagnostic pitfalls of hyalinizing trabecular adenoma and medullary thyroid carcinoma.
Hirokawa M; Matsuse M; Mitsutake N; Suzuki A; Higuchi M; Hayashi T; Kamma H; Miyauchi A; Akamizu T
Diagn Pathol; 2023 Jun; 18(1):74. PubMed ID: 37340328
[TBL] [Abstract] [Full Text] [Related]
12. Interleukin-6 promotes the dedifferentiation of papillary thyroid cancer cells.
Zhang GQ; Xi C; Shen CT; Song HJ; Luo QY; Qiu ZL
Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37260320
[TBL] [Abstract] [Full Text] [Related]
13. Metastatic recurrence of lung adenocarcinoma in thyroid clinically masquerading as primary thyroid cancer and immunohistochemically positive for thyroglobulin.
Yorita K; Hokimoto N; Tanida N; Matsuoka H
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37208007
[TBL] [Abstract] [Full Text] [Related]
14. SOX17 is a highly sensitive and specific marker for metastatic ovarian and endometrial carcinomas in cytology cell block specimens.
Satturwar S; Shaker N; Sinclair W; Shen R; Parwani AV; Ding Q; Li Z
Cancer Cytopathol; 2023 Jul; 131(7):465-470. PubMed ID: 37195085
[TBL] [Abstract] [Full Text] [Related]
15. Understanding and Overcoming the Pitfalls in Cytopathological Diagnosis of Hyalinizing Trabecular Tumor of thyroid.
Mahjabin F; Gonsalves C; Drew PA; Mukhtar F; Leon ME
Int J Surg Pathol; 2024 Feb; 32(1):91-96. PubMed ID: 37050854
[TBL] [Abstract] [Full Text] [Related]
16. Papillary thyroid carcinoma with aggressive fused follicular and solid growth pattern: A unique histological subtype with high-grade malignancy?
Murata SI; Matsuzaki I; Kishimoto M; Katsuki N; Onishi T; Hirokawa M; Kojima F
Pathol Int; 2023 May; 73(5):207-211. PubMed ID: 37042564
[TBL] [Abstract] [Full Text] [Related]
17. Unusual papillary thyroid carcinoma with hyalinizing trabecular tumor-like feature in a young female patient: a case report.
Umekita Y; Umeki K; Kawano F; Tanaka H; Kataoka H
J Med Case Rep; 2023 Mar; 17(1):112. PubMed ID: 36973752
[TBL] [Abstract] [Full Text] [Related]
18. An extremely rare case of nonfunctioning parathyroid carcinoma occurring in a parathyroid adenoma.
Nomura T; Moriya T; Miyoshi K
Med Mol Morphol; 2023 Jun; 56(2):152-158. PubMed ID: 36912960
[TBL] [Abstract] [Full Text] [Related]
19. Mesonephric-like adenocarcinoma of the ovary with squamoid morular metaplasia, aberrant β-catenin expression, and concurrent FGFR2 and CTNNB1 mutations: a case report.
Xu J; Park KJ; Rehrauer WM; Weisman PS
Virchows Arch; 2024 Jan; 484(1):147-150. PubMed ID: 36856760
[TBL] [Abstract] [Full Text] [Related]
20. SOX17: A Highly Sensitive and Specific Immunomarker for Ovarian and Endometrial Carcinomas.
Zhang X; Yao J; Niu N; Li X; Liu Y; Huo L; Euscher ED; Wang H; Bell D; Sood AK; Wang G; Lawson BC; Ramalingam P; Malpica A; Sahin AA; Ding Q; Liu J
Mod Pathol; 2023 Feb; 36(2):100001. PubMed ID: 36853778
[TBL] [Abstract] [Full Text] [Related]
[Next]
